Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 1,400 | 341 | 0 | 0 |
| Gross Profit | N/A | 1,400 | 341 | N/A | N/A |
| Operating Expenses | 1,616 | 1,386 | 2,990 | 1,243 | 931 |
| Operating Income | -1,616 | 14 | -2,649 | -1,243 | -931 |
| Interest Expense | 332 | 137 | 1,148 | 661 | 60 |
| Other Income | -39 | 705 | -861 | -1,578 | 0 |
| Pre-tax Income | -1,987 | 582 | -4,658 | -3,482 | -991 |
| Net Income Continuous | -1,987 | 582 | -4,658 | -3,482 | -991 |
| Net Income | $-1,987 | $582 | $-4,658 | $-3,482 | $-991 |
| EPS Basic Total Ops | -0.02 | 0.01 | -0.05 | 0.06 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | 0.01 | -0.05 | 0.06 | -0.01 |
| EPS Diluted Total Ops | -0.02 | 0.01 | -0.05 | 0.06 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | 0.01 | -0.05 | 0.06 | -0.01 |
| EBITDA(a) | $-1,218 | $240 | $-1,409 | $-564 | $-858 |